- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07602998
The Effect of Auditory Stimulation and the "Love Glove" Technique
The Effect of Auditory Stimulation and the "Love Glove" Technique on Vital Signs in Unconscious Patients
The aim of this study was to determine the effect of the "love glove" intervention, combined with the voices of family members and nurses, on vital signs in unconscious patients in the intensive care unit. The following items will be used to collect research data: Patient Information Form (Appendix I), Data Recording Form (Appendix II), MP3 player, external headphones and voice recorder, latex gloves, and thermometer.
Data Collection Tools:
Patient Identification Form : A form containing patients' sociodemographic characteristics and their Glasgow Coma Scale score prior to the start of the study Data Recording Form: A form used to record patients' level of consciousness and hemodynamic parameters before and after the auditory stimulation procedure.
Methods This study is a randomized controlled trial designed to determine the effect of applying a family member's voice, a nurse's voice, and the "love glove" on vital signs in unconscious patients admitted to the intensive care unit. Following approval from the ethics committee, the study is planned to be conducted with comatose patients admitted to the hospital's intensive care unit.
Panoramica dello studio
Stato
Condizioni
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
MANİSAYunusemre
-
Manisa, MANİSAYunusemre, Turchia (Türkiye)
- Kivan Çevik Kaya
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Patients in a coma who have been hospitalized in the intensive care unit for at least 48 hours, have a Glasgow Coma Scale score of 8 or lower,
- have no hearing problems,
- are hemodynamically stable,
- are either on mechanical ventilation or breathing spontaneously, have no history of head trauma,
- have received informed consent from their legal representative
Exclusion Criteria:
- Patients with open wounds,
- those diagnosed with brain death,
- those whose sedative or analgesic doses were adjusted during the study,
- those with severe hemodynamic instability,
- patients with latex allergies
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Nessun intervento: Controllo
Nessun intervento
|
|
|
Sperimentale: family member's voice
A pre-recorded message will be played and recorded for the patient's family members, featuring a prepared script that includes the patient's name, the family member's name, and their relationship to the patient, as well as information on the patient's location and phrases conveying hope and love.
|
The audio recording of the patient's family member will be made in a quiet and calm room.
Care will be taken to select family members who have a strong emotional bond with the patient for the recording.
When determining which family member will be recorded, the patient's first-degree relatives will be consulted, and the family's collective decision will be taken into account; in addition to the family member being recorded, consent will be obtained from another family member who volunteers to serve as a witness for this person via a consent form.
A preliminary interview will be conducted with the family member selected for the audio recording in a suitable room, and they will be asked to recite the standard script.
Family members will be given as much time as they need to prepare for the audio recording.
|
|
Sperimentale: nurse's voice
The audio recording made by the researcher will also be played for the other intervention group, to whom the nurse's voice will be played
|
The audio recording containing the standard script to be read by the researcher will also be made in a quiet, calm room
|
|
Sperimentale: Love glove
The group receiving the "love glove" treatment will be given a treatment involving latex gloves filled with warm water and air
|
Latex medical gloves will be filled with warm water (37°C) and air to prevent pressure ulcers and provide a sensation of human touch.
The gloves will be connected to each other and placed on both of the patient's hands, and the treatment will be applied for 15 minutes.
|
|
Sperimentale: family member's voice+glove of love
The patient's family members voice and the "glove of love" will be used together
|
where the patient's voice and the "glove of love" are used together
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
blood pressure
Lasso di tempo: Twice a day for 7 days
|
Blood pressure were recorded on the Form before and after the blood sampling procedure.
|
Twice a day for 7 days
|
|
pulse
Lasso di tempo: Twice a day for 7 days
|
Pulse were recorded on the Form before and after the blood sampling procedure.
|
Twice a day for 7 days
|
|
oxygen saturation
Lasso di tempo: Twice a day for 7 days
|
oxygen saturation were recorded on the Form before and after the blood sampling procedure.
|
Twice a day for 7 days
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- MCBU-K-CEVIK-006
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Stato incosciente
-
University of AberdeenSouth Eastern Health and Social Care TrustCompletatoMadri che sono state segnalate per il supporto genitorialeRegno Unito
-
Abramson Cancer Center of the University of PennsylvaniaRitiratoDonne adulte con una nuova diagnosi di carcinoma mammario invasivo (non sono state sottoposte a trattamento)
-
Ziqiang LiAttivo, non reclutanteDati statistici completi e accurati di 60 pazienti | I genotipi CYP3A5*3 di 60 donatori e riceventi sono stati analizzati accuratamente | Le concentrazioni postoperatorie di tacrolimus sono state accuratamente registrate in 60 pazienti | Secondo i criteri di diagnosi e classificazione della... e altre condizioniCina